Macaya C

Idioma: Español
Referencias bibliográficas: 10
Paginas: 406-409
Archivo PDF: 50.61 Kb.

RESUMEN

La reestenosis coronaria después de la angioplastía ha sido considerada como la secuela principal a resolver para garantizar un mayor éxito. La colocación de stents ha provisto una solución parcial que se ve favorecida con la aplicación de stents liberadores de fármacos como sirolimus y taxol.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al: A comparison of balloon expandable-stent implantation with ballon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.

2. Hoffmann R, Mintz GS, Dussaillant Gr, et al: Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.

3. de Feyter PJ, Vos J, Rensing BJ: Anti-restenosis trials. Curr Inter Cardiol Rep 2000; 2: 326-31.

4. Suzuki T, Kopia G, Hayashi S, et al: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-93.

5. Sousa JE, Costa MA, Abizaid A, et al: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-5.

6. Sousa JE, Costa MA, Sousa AG, et al: Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107: 381-383.

7. Marie Claude Morice, Patrick W. Serruys J, Eduardo Sousa, et al: N Engl J Med 2002; 346: 1773-80.

8. Park SJ, Shim WH, Ho DS, et al: A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537-1545.

9. Moses JW, Leon MB, Popma JJ, et al: Sirolimus eluting stents versus standard stents in patients with restenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.

10. Schofer J, Schulter M, Gershlich AH, et al: Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.